stay updated with our newsletter

Share Practice Poll on Stress

neurobiology of stress

Each week Share Practice presents a polling question to integrative physicians on preferred protocols. Today’s Practitioner will share these with you from time to time to get your thoughts on whether you agree. Q: A 37 y/o woman, CEO of a tech startup, reports emotional stress, increasing anxiety, poor appetiteRead

Research Review for Dietary Acid Load

The concept of alkaline balance and diet has been known for some years with limited wide-scale practice. Recent studies show that acid-base balance in the diet may indeed play an important role in cardio-metabolic abnormalities, including type 2 diabetes. The following is a summary of two supporting studies. High dietaryRead

Seven Principles of Integrative Care, White Paper

Todays Practitioner, Digital, Medicine,

The following is an excerpt of a white paper in the seven principles of integrative care, The Pebble in the Pond, How Integrative Leadership Can Bring About Transformation, from Duke University Integrative Medicine. Download the white paper at the end of this post. Principles of Integrative Care Integrative Healthcare aroseRead

Case Study: A Novel Approach to Thyroid and Adrenal Therapy

This case study represents a common problem for integrative-care physicians. Where do you start with a patient with multiple symptoms that may be complicated by previous drug therapies. “One of the many challenges for any physician is determining the correct course of treatment for patients with more than 1 area of complaint. Should the physician treat the symptoms or the underlying cause of a condition?,” writes Christopher Wellwood MS, DC and Sean Rardin, MD. This case study of a 49-year old patient with multiple symptoms, including a goiter, as well as hyperlipidemia; multiple joint pains; alopecia; fatigue; bilateral, lowerextremity edema; and severe gastric disruption with bloating and acid reflux. By Wellwood, Rardin, published in Integrative Medicine a Clinicians Journal, June 2014.

Omega-3 & ALA Fatty Acids May Reduce Lou Gehrig’s Disease Risk

Omega-3 fatty acids may play a role in cutting one’s risk of fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) by one third, a new study suggests from the Harvard School of Public Health in Boston. The research suggests that EFA’s could be part of prevention or integrative therapeutic treatment for ALS. By Kathryn C. Fitzgerald, M.Sc, JAMA Neurology, July 2014.

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.